Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician
Low-density lipoproteins were above clinically acceptable levels at 3.77 mmol/l. The participant had an elevated level of alanine transaminase indicative of reduction in liver function. In addition, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback